230 related articles for article (PubMed ID: 29253717)
1. Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.
Akhter R; Shao Y; Shaw M; Formica S; Khrestian M; Leverenz JB; Bekris LM
Neurobiol Aging; 2018 Mar; 63():110-119. PubMed ID: 29253717
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
[TBL] [Abstract][Full Text] [Related]
3. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10.
Augustin R; Endres K; Reinhardt S; Kuhn PH; Lichtenthaler SF; Hansen J; Wurst W; Trümbach D
BMC Med Genet; 2012 May; 13():35. PubMed ID: 22594617
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
[TBL] [Abstract][Full Text] [Related]
5. microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.
Manzine PR; Pelucchi S; Horst MA; Vale FAC; Pavarini SCI; Audano M; Mitro N; Di Luca M; Marcello E; Cominetti MR
J Alzheimers Dis; 2018; 61(1):113-123. PubMed ID: 29036829
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mRNA and Protein Levels of
Di Maio A; De Rosa A; Pelucchi S; Garofalo M; Marciano B; Nuzzo T; Gardoni F; Isidori AM; Di Luca M; Errico F; De Bartolomeis A; Marcello E; Usiello A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163460
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
Shackleton B; Crawford F; Bachmeier C
Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.
Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP
FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor apicidin increases expression of the α-secretase ADAM10 through transcription factor USF1-mediated mechanisms.
Hu XT; Zhu BL; Zhao LG; Wang JW; Liu L; Lai YJ; He L; Deng XJ; Chen GJ
FASEB J; 2017 Apr; 31(4):1482-1493. PubMed ID: 28003340
[TBL] [Abstract][Full Text] [Related]
10. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
12. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
Liu F; Zhuang L; Wu R; Li D
J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854
[TBL] [Abstract][Full Text] [Related]
13. The Role of ADAM10 in Alzheimer's Disease.
Yuan XZ; Sun S; Tan CC; Yu JT; Tan L
J Alzheimers Dis; 2017; 58(2):303-322. PubMed ID: 28409746
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis.
Ou ZL; Luo Z; Wei W; Liang S; Gao TL; Lu YB
RNA Biol; 2019 Nov; 16(11):1592-1603. PubMed ID: 31402756
[TBL] [Abstract][Full Text] [Related]
15. miR-23b Negatively Regulates Sepsis-Induced Inflammatory Responses by Targeting ADAM10 in Human THP-1 Monocytes.
Zhang W; Lu F; Xie Y; Lin Y; Zhao T; Tao S; Lai Z; Wei N; Yang R; Shao Y; He J
Mediators Inflamm; 2019; 2019():5306541. PubMed ID: 31780861
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
17. Sox2 functionally interacts with βAPP, the βAPP intracellular domain and ADAM10 at a transcriptional level in human cells.
Sarlak G; Htoo HH; Hernandez JF; Iizasa H; Checler F; Konietzko U; Song W; Vincent B
Neuroscience; 2016 Jan; 312():153-64. PubMed ID: 26592717
[TBL] [Abstract][Full Text] [Related]
18. Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks.
Reinhardt S; Stoye N; Luderer M; Kiefer F; Schmitt U; Lieb K; Endres K
Sci Rep; 2018 Jan; 8(1):1329. PubMed ID: 29358714
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
[TBL] [Abstract][Full Text] [Related]
20. [miR-140-5p affects the migration and invasion of hypopharyngeal carcinoma cells by downregulating ADAM10 expression].
Jing P; Sa N; Xu W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 51(3):189-96. PubMed ID: 27033573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
